2023 OBIO Investment Summit Overview
Summit Highlights
Launch of the Pharmaceutical Licensing Forum (PLF) that connects Canadian biotechs, Canadian universities and global pharma to partner on in- and out-licensing deals.
Presentations from 79 of Canada’s most innovative companies bringing health science innovations in regenerative medicine, gene editing, stem cell therapy, immunotherapy, development platforms, surgical devices, medical diagnostics, and more.
140 US and global venture capitalists (VC) and corporate VC investors.
Early Technology Showcase featuring the most promising technologies & projects with the greatest potential for commercialization and emerging health science companies from 12 of Canada’s leading research institutions and health organizations.
Presentations and panel discussions on cutting-edge topics, featuring leading industry voices addressing critical commercial, scientific, and market access issues.
500+ partnering meetings between investors, companies & ecosystem partners.
Links
“Nurturing the ecosystem that supports Canada’s best health science innovators is key to success. Events like this go a long way towards supporting the growth of a strong and competitive domestic life science sector securing Canada’s ability to deliver healthcare solutions to Canadians and the world. The OBIO Investment Summit will greatly help the emergence of a world-class private biotech industry in Canada.”